Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Calgary
$105,000.00
Exploring the neuroprotective effects of carbon dioxide inhalation following spinal cord injury
EF 2022-23
Résumé
Spinal cord injury (SCI) is a life-changing event that has profound physical, psychosocial, and economic impacts. SCI severity is determined by both primary and secondary injuries. The primary injury refers to the direct mechanical damage to the spinal cord and is often irreversible. The secondary injury refers to damage occurring after the primary event and may increase the severity of the injury up to 50%. Secondary injuries are caused by a reduction in substrate provision and accumulation of metabolic and neurogenic by-products at the injury site. Limiting the extent of secondary injury during the acute phase of SCI is critical for improving functional outcomes. It is accepted that secondary SCI may be mitigated by improving blood flow to the injury site. The problem is that following SCI, blood flow is restricted to the injury due to a reduction in systemic blood pressure and damage to blood vessels within the spinal cord. In the emergency room, this problem is treated with pharmacologic agents that increase blood pressure but critically, these interventions may actually decrease spinal cord blood flow because of increased vascular resistance. We put forward the idea that carbon dioxide (CO2) gas can be used to treat secondary SCI. CO2 is a natural by-product of metabolism and a powerful controller of blood flow in the brain. Recent work has revealed that clinical outcomes after brain injury are improved by regulating the concentration of inhaled CO2. We do not yet understand whether CO2 has similar effects on the spinal cord following injury. Using spinal mice as a pre-clinical model, we will address three aims. First, we will examine the effects of inhaled CO2 on blood flow and oxygen delivery to the SCI. Second, we will test whether we can administer an optimal concentration of CO2 to stabilize fluctuations in blood flow following SCI. Third, we will examine whether tightly controlled CO2 administration improves long-term behavioural outcomes after SCI.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
475973
Name
Miller Ryan R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Exploring the neuroprotective effects of carbon dioxide inhalation following spinal cord injury
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Autonomic Nervous System; Biomedical Engineering; Cardiovascular Medicine; Closed Loop Pid Controller; Emergency Medicine; Hemodynamics; Hemotherapy; Hypercapnia; Motor Control; Spinal Cord Injury
Abstract
Spinal cord injury (SCI) is a life-changing event that has profound physical, psychosocial, and economic impacts. SCI severity is determined by both primary and secondary injuries. The primary injury refers to the direct mechanical damage to the spinal cord and is often irreversible. The secondary injury refers to damage occurring after the primary event and may increase the severity of the injury up to 50%. Secondary injuries are caused by a reduction in substrate provision and accumulation of metabolic and neurogenic by-products at the injury site. Limiting the extent of secondary injury during the acute phase of SCI is critical for improving functional outcomes. It is accepted that secondary SCI may be mitigated by improving blood flow to the injury site. The problem is that following SCI, blood flow is restricted to the injury due to a reduction in systemic blood pressure and damage to blood vessels within the spinal cord. In the emergency room, this problem is treated with pharmacologic agents that increase blood pressure but critically, these interventions may actually decrease spinal cord blood flow because of increased vascular resistance. We put forward the idea that carbon dioxide (CO2) gas can be used to treat secondary SCI. CO2 is a natural by-product of metabolism and a powerful controller of blood flow in the brain. Recent work has revealed that clinical outcomes after brain injury are improved by regulating the concentration of inhaled CO2. We do not yet understand whether CO2 has similar effects on the spinal cord following injury. Using spinal mice as a pre-clinical model, we will address three aims. First, we will examine the effects of inhaled CO2 on blood flow and oxygen delivery to the SCI. Second, we will test whether we can administer an optimal concentration of CO2 to stabilize fluctuations in blood flow following SCI. Third, we will examine whether tightly controlled CO2 administration improves long-term behavioural outcomes after SCI.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Miller, Ryan R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~